Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Malabi M Venkatesan & Lillian L Van de Verg. (2015) Combination vaccines against diarrheal diseases. Human Vaccines & Immunotherapeutics 11:6, pages 1434-1448.
Read now
Read now
Ana Isabel Camacho, Juan Manuel Irache & Carlos Gamazo. (2013) Recent progress towards development of a Shigella vaccine. Expert Review of Vaccines 12:1, pages 43-55.
Read now
Read now
Abbas Muhammad, Jonathan Champeimont, Ulrike Beate Mayr, Werner Lubitz & Pavol Kudela. (2012) Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert Review of Vaccines 11:1, pages 97-116.
Read now
Read now
Articles from other publishers (56)
Namrata Baruah, Prolay Halder, Hemanta Koley & Dhirendra S. Katti. (2022) Stable Recombinant Invasion Plasmid Antigen C (IpaC)-Based Single Dose Nanovaccine for Shigellosis. Molecular Pharmaceutics 19:11, pages 3884-3893.
Crossref
Crossref
Ahmad Nasser, Mehrdad Mosadegh, Taher Azimi & Aref Shariati. (2022) Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population. Molecular and Cellular Pediatrics 9:1.
Crossref
Crossref
Richard Walker, Robert W. Kaminski, Chad Porter, Robert K. M. Choy, Jessica A. White, James M. Fleckenstein, Fred Cassels & Louis Bourgeois. (2021) Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease. Microorganisms 9:7, pages 1382.
Crossref
Crossref
Ahtesham Ahmad Shad & Wajahat Ahmed Shad. (2020) Shigella sonnei: virulence and antibiotic resistance. Archives of Microbiology 203:1, pages 45-58.
Crossref
Crossref
Yrvin León, Lionel Zapata, Raúl E. Molina, Gaj Okanovič, Leonardo A. Gómez, Carla Daza-Castro, Manuel Flores-Concha, José L. Reyes & Angel A. Oñate. (2020) Intranasal Immunization of Mice with Multiepitope Chimeric Vaccine Candidate Based on Conserved Autotransporters SigA, Pic and Sap, Confers Protection against Shigella flexneri. Vaccines 8:4, pages 563.
Crossref
Crossref
Bakhos Jneid, Audrey Rouaix, Cécile Féraudet-Tarisse & Stéphanie Simon. (2020) SipD and IpaD induce a cross-protection against Shigella and Salmonella infections. PLOS Neglected Tropical Diseases 14:5, pages e0008326.
Crossref
Crossref
Farhad Gilavand, Abdolrazagh Marzban, Gholamhossein Ebrahimipour, Neda Soleimani & Mehdi Goudarzi. (2020) Designation of chitosan nano-vaccine based on MxiH antigen of Shigella flexneri with increased immunization capacity. Carbohydrate Polymers 232, pages 115813.
Crossref
Crossref
Marcela F. Pasetti, Malabi M. Venkatesan & Eileen M. Barry. 2020. Mucosal Vaccines. Mucosal Vaccines
515
536
.
Mokhtar Nosrati, Abbas Hajizade, Shahram Nazarian, Jafar Amani, Amir Namvar Vansofla & Yousof Tarverdizadeh. (2019) Designing a multi-epitope vaccine for cross-protection against Shigella spp: An immunoinformatics and structural vaccinology study. Molecular Immunology 116, pages 106-116.
Crossref
Crossref
Neil Ravenscroft, Martin Braun, Joerg Schneider, Anita M Dreyer, Michael Wetter, Micha A Haeuptle, Stefan Kemmler, Michael Steffen, Dominique Sirena, Stefan Herwig, Paula Carranza, Claire Jones, Andrew J Pollard, Michael Wacker & Michael Kowarik. (2019) Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate. Glycobiology 29:9, pages 669-680.
Crossref
Crossref
Christina S. Faherty & Keith A. Lampel. 2019. Food Microbiology. Food Microbiology
317
345
.
Mohammad Mehdi Adibzadeh Sereshgi, Meghdad Abdollahpour-Alitappeh, Mehdi Mahdavi, Reza Ranjbar, Kazem Ahmadi, Ramezan Ali Taheri & Mahdi Fasihi-Ramandi. (2019) Immunologic balance of regulatory T cell/T helper 17 responses in gastrointestinal infectious diseases: Role of miRNAs. Microbial Pathogenesis 131, pages 135-143.
Crossref
Crossref
Sihan Wang, Jin Gao & Zhenjia Wang. (2018) Outer membrane vesicles for vaccination and targeted drug delivery. WIREs Nanomedicine and Nanobiotechnology 11:2.
Crossref
Crossref
Ibrahim A Khalil, Christopher Troeger, Brigette F Blacker, Puja C Rao, Alexandria Brown, Deborah E Atherly, Thomas G Brewer, Cyril M Engmann, Eric R Houpt, Gagandeep Kang, Karen L Kotloff, Myron M Levine, Stephen P Luby, Calman A MacLennan, William K Pan, Patricia B Pavlinac, James A Platts-Mills, Firdausi Qadri, Mark S Riddle, Edward T Ryan, David A Shoultz, A Duncan Steele, Judd L Walson, John W Sanders, Ali H Mokdad, Christopher J L Murray, Simon I Hay & Robert C ReinerJrJr. (2018) Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016. The Lancet Infectious Diseases 18:11, pages 1229-1240.
Crossref
Crossref
M.S. Riddle, W.H. Chen, C.D. Kirkwood & C.A. MacLennan. (2018) Update on vaccines for enteric pathogens. Clinical Microbiology and Infection 24:10, pages 1039-1045.
Crossref
Crossref
Esther Ndungo, Arlo Randall, Tracy H. Hazen, Dane A. Kania, Krista Trappl-Kimmons, Xiaowu Liang, Eileen M. Barry, Karen L. Kotloff, Subhra Chakraborty, Sachin Mani, David A. Rasko & Marcela F. Pasetti. (2018)
A Novel
Shigella
Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge
. mSphere 3:4.
Crossref
Crossref
Robert W FrenckJr.Jr., Shahida Baqar, William Alexander, Michelle Dickey, Monica McNeal, Jill El-Khorazaty, Holly Baughman, Amy Hoeper, Shoshana Barnoy, Akamol E. Suvarnapunya, Robert W. Kaminski & Malabi M. Venkatesan. (2018) A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei. Vaccine 36:32, pages 4880-4889.
Crossref
Crossref
Cinzia Colombo, Olimpia Pitirollo & Luigi Lay. (2018) Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development. Molecules 23:7, pages 1712.
Crossref
Crossref
Sapna Pahil, Neelam Taneja, Hifzur Rahman Ansari & G. P. S. Raghava. (2017) In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. PLOS ONE 12:8, pages e0180505.
Crossref
Crossref
Odile Launay, David J.M. Lewis, Alessandra Anemona, Pierre Loulergue, Jo Leahy, Antonella Silvia Sciré, Anaïs Maugard, Elisa Marchetti, Stefano Zancan, Zhiming Huo, Simona Rondini, Rachid Marhaba, Oretta Finco, Laura B. Martin, Jochen Auerbach, Daniel Cohen, Allan Saul, Christiane Gerke & Audino Podda. (2017) Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. EBioMedicine 22, pages 164-172.
Crossref
Crossref
Wilbur H. Chen & Karen L. Kotloff. (2016) Shigella Vaccine Development: Finding the Path of Least Resistance. Clinical and Vaccine Immunology 23:12, pages 904-907.
Crossref
Crossref
Mark S. Riddle, Robert W. Kaminski, Claudio Di Paolo, Chad K. Porter, Ramiro L. Gutierrez, Kristen A. Clarkson, Hailey E. Weerts, Christopher Duplessis, Amy Castellano, Cristina Alaimo, Kristopher Paolino, Robert Gormley & Veronica Gambillara Fonck. (2016) Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. Clinical and Vaccine Immunology 23:12, pages 908-917.
Crossref
Crossref
Sachin Mani, Thomas Wierzba & Richard I. Walker. (2016) Status of vaccine research and development for Shigella. Vaccine 34:26, pages 2887-2894.
Crossref
Crossref
Robert M. F. van der Put, Tae Hee Kim, Catherine Guerreiro, Françoise Thouron, Peter Hoogerhout, Philippe J. Sansonetti, Janny Westdijk, Michiel Stork, Armelle Phalipon & Laurence A. Mulard. (2016) A Synthetic Carbohydrate Conjugate Vaccine Candidate against Shigellosis: Improved Bioconjugation and Impact of Alum on Immunogenicity. Bioconjugate Chemistry 27:4, pages 883-892.
Crossref
Crossref
Subhra Chakraborty, Clayton Harro, Barbara DeNearing, Jay Bream, Nicole Bauers, Len Dally, Jorge Flores, Lillian Van de Verg, David A. Sack & Richard Walker. (2016) Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects. Clinical and Vaccine Immunology 23:4, pages 315-325.
Crossref
Crossref
A. Mutreja. 2016. Medical and Health Genomics. Medical and Health Genomics
101
106
.
B. GU, M. ZHOU, X. KE, S. PAN, Y. CAO, Y. HUANG, L. ZHUANG, G. LIU & M. TONG. (2015)
Comparison of resistance to third-generation cephalosporins in
Shigella
between Europe-America and Asia-Africa from 1998 to 2012
. Epidemiology and Infection 143:13, pages 2687-2699.
Crossref
Crossref
Christiane Gerke, Anna Maria Colucci, Carlo Giannelli, Silvia Sanzone, Claudia Giorgina Vitali, Luigi Sollai, Omar Rossi, Laura B. Martin, Jochen Auerbach, Vito Di Cioccio & Allan Saul. (2015) Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLOS ONE 10:8, pages e0134478.
Crossref
Crossref
Malabi M Venkatesan. (2015)
A novel protein‐based subunit
Shigella
vaccine candidate
. Immunology & Cell Biology 93:7, pages 603-604.
Crossref
Crossref
Richard I. Walker. (2015) An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children. Vaccine 33:8, pages 954-965.
Crossref
Crossref
Wilmara Salgado-Pabón, Christoph Konradt, Philippe J. Sansonetti & Armelle Phalipon. (2014) New insights into the crosstalk between Shigella and T lymphocytes. Trends in Microbiology 22:4, pages 192-198.
Crossref
Crossref
R. W. Kaminski, M. Wu, K. R. Turbyfill, K. Clarkson, B. Tai, A. L. Bourgeois, L. L. Van De Verg, R. I. Walker & E. V. Oaks. (2014) Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine. Clinical and Vaccine Immunology 21:3, pages 366-382.
Crossref
Crossref
Shannon J. Heine, Jovita Diaz-McNair, Abhay U. Andar, Cinthia B. Drachenberg, Lillian van de Verg, Richard Walker, Wendy L. Picking & Marcela F. Pasetti. (2014)
Intradermal Delivery of
Shigella
IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes
. The Journal of Immunology 192:4, pages 1630-1640.
Crossref
Crossref
Charles Gauthier, Pierre Chassagne, François-Xavier Theillet, Catherine Guerreiro, Françoise Thouron, Farida Nato, Muriel Delepierre, Philippe J. Sansonetti, Armelle Phalipon & Laurence A. Mulard. (2014) Non-stoichiometric O-acetylation of Shigella flexneri 2a O-specific polysaccharide: synthesis and antigenicity. Org. Biomol. Chem. 12:24, pages 4218-4232.
Crossref
Crossref
D. Jahantigh, M. Saadati, M. Fasihi Ramandi, M. Mousavi & A.M. Zand. (2014) Novel Intranasal Vaccine Delivery System by Chitosan Nanofibrous Membrane Containing N-Terminal Region of Ipad Antigen as a Nasal Shigellosis Vaccine, Studies in Guinea Pigs. Journal of Drug Delivery Science and Technology 24:1, pages 33-39.
Crossref
Crossref
Soumik Barman, Hemanta Koley, Thandavarayan Ramamurthy, Manoj Kumar Chakrabarti, Sumio Shinoda, Gopinath Balakrish Nair & Yoshifumi Takeda. (2013)
Protective immunity by oral immunization with heat-killed
Shigella
strains in a guinea pig colitis model
. Microbiology and Immunology 57:11, pages 762-771.
Crossref
Crossref
A.I. Camacho, J.M. Irache, J. de Souza, S. Sánchez-Gómez & C. Gamazo. (2013) Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine 31:32, pages 3288-3294.
Crossref
Crossref
Rezwanul Wahid, Jakub K. Simon, Wendy L. Picking, Karen L. Kotloff, Myron M. Levine & Marcelo B. Sztein. (2013) Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. Clinical Immunology 148:1, pages 35-43.
Crossref
Crossref
Pierre Chassagne, Carolina Fontana, Catherine Guerreiro, Charles Gauthier, Armelle Phalipon, Göran Widmalm & Laurence A. Mulard. (2013)
Structural Studies of the
O
-Acetyl-Containing O-Antigen from a
Shigella flexneri
Serotype 6 Strain and Synthesis of Oligosaccharide Fragments Thereof
. European Journal of Organic Chemistry 2013:19, pages 4085-4106.
Crossref
Crossref
Soma Mitra, Manoj K. Chakrabarti & Hemanta Koley. (2013) Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis. Vaccine 31:31, pages 3163-3173.
Crossref
Crossref
Shannon J. Heine, Jovita Diaz-McNair, Francisco J. Martinez-Becerra, Shyamal P. Choudhari, John D. Clements, Wendy L. Picking & Marcela F. Pasetti. (2013) Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. Vaccine 31:28, pages 2919-2929.
Crossref
Crossref
A.I. Camacho, J. Souza-Rebouças, J.M. Irache & C. Gamazo. (2013) Towards a non-living vaccine against Shigella flexneri: From the inactivation procedure to protection studies. Methods 60:3, pages 264-268.
Crossref
Crossref
Sumon Kumar Das, Shahnawaz Ahmed, Farzana Ferdous, Fahmida Dil Farzana, Mohammod Jobayer Chisti, Daniel T. Leung, Mohammad Abdul Malek, Kaisar Ali Talukder, Pradip Kumar Bardhan, Mohammed Abdus Salam, Abu Syed Golam Faruque & Rubhana Raqib. (2013) Changing Emergence of Shigella Sero-Groups in Bangladesh: Observation from Four Different Diarrheal Disease Hospitals. PLoS ONE 8:4, pages e62029.
Crossref
Crossref
Madushini N. Dharmasena, Brock W. Hanisch, Tint T. Wai & Dennis J. Kopecko. (2013) Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. International Journal of Medical Microbiology 303:3, pages 105-113.
Crossref
Crossref
Rachel Binet & Keith A. Lampel. 2012. Food Microbiology. Food Microbiology
377
399
.
Zhili Chang, Shuting Lu, Lihong Chen, Qi Jin & Jian Yang. (2012) Causative Species and Serotypes of Shigellosis in Mainland China: Systematic Review and Meta-Analysis. PLoS ONE 7:12, pages e52515.
Crossref
Crossref
Kathryn E Holt, Stephen Baker, François-Xavier Weill, Edward C Holmes, Andrew Kitchen, Jun Yu, Vartul Sangal, Derek J Brown, John E Coia, Dong Wook Kim, Seon Young Choi, Su Hee Kim, Wanderley D da Silveira, Derek J Pickard, Jeremy J Farrar, Julian Parkhill, Gordon Dougan & Nicholas R Thomson. (2012) Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe. Nature Genetics 44:9, pages 1056-1059.
Crossref
Crossref
Ryan T. Ranallo, Suramya Fonseka, Tara L. Boren, Lisa A. Bedford, Robert W. Kaminski, Sejal Thakkar & Malabi M. Venkatesan. (2012) Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: A new combination of gene deletions for 2nd generation live attenuated vaccine candidates. Vaccine 30:34, pages 5159-5171.
Crossref
Crossref
Francesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, Silvia Sanzone, Omar Rossi, Ilaria Ferlenghi, Isabella Pesce, Mariaelena Caboni, Nathalie Norais, Vito Di Cioccio, Allan Saul & Christiane Gerke. (2012) High Yield Production Process for Shigella Outer Membrane Particles. PLoS ONE 7:6, pages e35616.
Crossref
Crossref
François-Xavier Theillet, Pierre Chassagne, Muriel Delepierre, Armelle Phalipon & Laurence A. Mulard. 2012. Anticarbohydrate Antibodies. Anticarbohydrate Antibodies
1
36
.
S.N. Chatterjee & Keya ChaudhuriS. N. Chatterjee & Keya Chaudhuri. 2012. Outer Membrane Vesicles of Bacteria. Outer Membrane Vesicles of Bacteria
95
145
.
A.I. Camacho, J. de Souza, S. Sánchez-Gómez, M. Pardo-Ros, J.M. Irache & C. Gamazo. (2011) Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine 29:46, pages 8222-8229.
Crossref
Crossref
Mark S. Riddle, Robert W. Kaminski, Carlos Williams, Chad Porter, Shahida Baqar, Alexis Kordis, Theron Gilliland, Joyce Lapa, Melissa Coughlin, Chris Soltis, Erica Jones, Jackie Saunders, Paul B. Keiser, Ryan T. Ranallo, Robert Gormley, Michael Nelson, K. Ross Turbyfill, David Tribble & Edwin V. Oaks. (2011) Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine. Vaccine 29:40, pages 7009-7019.
Crossref
Crossref
S. Barnoy, S. Baqar, R.W. Kaminski, T. Collins, K. Nemelka, T.L. Hale, R.T. Ranallo & M.M. Venkatesan. (2011) Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. Vaccine 29:37, pages 6371-6378.
Crossref
Crossref
Margaret Kosek, Pablo Peñataro Yori & Maribel Paredes Olortegui. (2010) Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas. Current Opinion in Infectious Diseases 23:5, pages 475-480.
Crossref
Crossref
D. Tribble, R. Kaminski, J. Cantrell, M. Nelson, C. Porter, S. Baqar, C. Williams, R. Arora, J. Saunders, M. Ananthakrishnan, J. Sanders, G. Zaucha, R. Turbyfill & E. Oaks. (2010) Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers. Vaccine 28:37, pages 6076-6085.
Crossref
Crossref